Follow The Filings

KYMR Kymera Therapeutics

Kymera Therapeutics earnings company data as of 4:46 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by KYMR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All KYMR insider trades
  • $172M bought by 1 insider
  • $195M sold by 2 insiders outside a trading plan
  • $267M sold by 9 insiders under 10b5-1 plans
  1. Nello Mainolfi CEO
    Planned sale
    $3.4M 30,000 shares at $113.80 4.3% of stake
    Traded Oct 1 Filed Oct 1
    ↗
  2. Nello Mainolfi CEO
    Planned sale
    $6M 50,000 shares at $119.00 7% of stake
    Traded Jul 7 Filed Jul 7
    ↗
  3. Bruce Booth Director
    Planned sale
    $8.3M 76,650 shares at $108.05 14% of stake
    Traded Jun 29 Filed Jul 2
    ↗
  4. Bruce N. Jacobs CFO
    Planned sale
    $8.9M 77,109 shares at $114.96 24% of stake
    Traded Jun 30 Filed Jul 2
    ↗
  5. Noah Goodman Chief Business Officer
    Planned sale
    $387K 3,389 shares at $114.29 6.7% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  6. Nello Mainolfi CEO
    Planned sale
    $9.2M 80,000 shares at $115.29 11% of stake
    Traded Jul 1 Filed Jul 2
    ↗
  7. Bruce Booth Director
    Planned sale
    $51.6M 467,878 shares at $110.29 50% of stake
    Traded Jun 26 Filed Jun 30
    ↗
  8. Bvf Partners L P Director, +9 joint filers
    Sale
    $174M 1,630,658 shares at $106.50
    Traded Jun 26 Filed Jun 26
    ↗
  9. Bruce Booth Director
    Planned sale
    $34.8M 285,684 shares at $121.86 35% of stake
    Traded Jun 25 Filed Jun 25
    ↗
  10. Bruce Booth Director
    Planned sale
    $44M 398,765 shares at $110.31 41% of stake
    Traded Jun 23–25 Filed Jun 25
    ↗
  11. Noah Goodman Chief Business Officer
    Planned sale
    $570K 5,000 shares at $114.00 9.1% of stake
    Traded Jun 25 Filed Jun 25
    ↗
  12. Bruce Booth Director
    Planned sale
    $3.3M 31,798 shares at $103.75 4.9% of stake
    Traded Jun 22 Filed Jun 22
    ↗
  13. Bruce Booth Director
    Planned sale
    $45.3M 478,198 shares at $94.72
    Traded Jun 17–22 Filed Jun 22
    ↗
  14. Noah Goodman Chief Business Officer
    Planned sale
    $248K 2,500 shares at $99.00 4.7% of stake
    Traded Jun 22 Filed Jun 22
    ↗
  15. Jeremy G Chadwick COO
    Planned sale
    $1.1M 13,130 shares at $80.38 23% of stake
    Traded May 26–27 Filed May 27
    ↗

Also filed in the last 12 months, not counted as buying or selling: 44 option exercises, 28 sales to cover taxes, and 6 stock grants.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.